IRCT20201126049497N2
Not yet recruiting
未知
Evaluation of lymphocyte therapy effects on treatment of women with unexplained Recurrent Spontaneous Abortion (RSA)
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Recurrent spontaneous abortion.
- Sponsor
- Birjand University of Medical Sciences
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The age range from 18 to 35 years
- •The presence of repeated miscarriages with unknown reasons and the possibility of immunological reasons
- •Presence of APCA antibody percentage lower than 5%
Exclusion Criteria
- •Presence of abortion with known non\-immunological causes
- •Presence of APCA antibody percentage higher than 5%
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Evaluating changes in orthodontic tooth movement with use of different blood derivatives.CTRI/2024/08/071908Dr Aastha Kamrani
Completed
Not Applicable
To evaluate effect of immunotherapy .Health Condition 1: - Health Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxCTRI/2024/02/062655HCG NCHRI Cancer Centre10
Recruiting
Phase 3
Evaluation of therapeutic effects of Crocina in knee osteoarthritisosteoarthritis.Primary osteoarthritis of other jointsM19.0IRCT20190419043318N1Bojnourd University of Medical Sciences60
Unknown
Phase 3
A study to evaluate the effects of human lymphoblastoid interferon (HLBI) in hepatitis C patients with compensated cirrhosis.Chronic hepatitis C with compensated cirrhosisJPRN-jRCT2080220477Dainippon Sumitomo Pharma Co., Ltd.
Recruiting
Phase 2
Efficacy stem cells in improving the symptoms of patients with lupusIRCT20130812014333N182Kermanshah University of Medical Sciences20